Indian Scientists Develop 'Smart' Cancer Drug RK-251

Researchers from IASST and IIT-Guwahati have developed a 'smart' cancer drug, RK-251, designed to target cancer cells specifically while sparing healthy tissue.

The drug is being positioned as a potential alternative to traditional chemotherapy, which often causes severe side effects due to its non-targeted nature.

Initial findings suggest the drug is particularly effective against aggressive breast cancer, with further research underway to determine its broader clinical applications.